Woodline Partners’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,111,123
| Closed | -$2.63M | – | 677 |
|
2024
Q1 | $2.63M | Hold |
1,111,123
| – | – | 0.02% | 409 |
|
2023
Q4 | $2.5M | Hold |
1,111,123
| – | – | 0.03% | 364 |
|
2023
Q3 | $2.36M | Hold |
1,111,123
| – | – | 0.03% | 383 |
|
2023
Q2 | $3.43M | Hold |
1,111,123
| – | – | 0.04% | 348 |
|
2023
Q1 | $5.98M | Hold |
1,111,123
| – | – | 0.08% | 264 |
|
2022
Q4 | $7.39M | Hold |
1,111,123
| – | – | 0.1% | 258 |
|
2022
Q3 | $4.42M | Hold |
1,111,123
| – | – | 0.06% | 320 |
|
2022
Q2 | $5.52M | Hold |
1,111,123
| – | – | 0.09% | 245 |
|
2022
Q1 | $6.71M | Hold |
1,111,123
| – | – | 0.11% | 215 |
|
2021
Q4 | $12.9M | Hold |
1,111,123
| – | – | 0.18% | 153 |
|
2021
Q3 | $17.4M | Sell |
1,111,123
-35,371
| -3% | -$555K | 0.28% | 98 |
|
2021
Q2 | $21.4M | Sell |
1,146,494
-6,773
| -0.6% | -$126K | 0.4% | 64 |
|
2021
Q1 | $49.7M | Buy |
+1,153,267
| New | +$49.7M | 1.1% | 14 |
|